Matthew Buten - 08 Dec 2021 Form 4 Insider Report for Biohaven Pharmaceutical Holding Co Ltd.

Role
Officer
Signature
/s/ George Clark, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
08 Dec 2021
Net transactions value
$0
Form type
4
Filing time
14 Dec 2021, 19:52:43 UTC
Next filing
04 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHVN Restricted Share Unit Award Award +50,000 50,000 08 Dec 2021 Common Shares 50,000 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted share unit represents the contingent right to receive one common share of the issuer.
F2 The reporting person was granted 50,000 restricted share units on December 8, 2021. 12,500 of the restricted share units vested on December 8, 2021 and are subject to deferred settlement. The remainder vest in three equal installments on December 8, 2022, 2023 and 2024 subject to the reporting person's continued service with the issuer at each vesting date.
F3 Not applicable.